Seamus Fernandez - Guggenheim Analyst Performance This page shows the methodology used to calculate Seamus Fernandez's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsGPCRStructure Therapeutics8/7/2025$16.18$90.00Buy???%???%RYTMRhythm Pharmaceuticals8/6/2025$89.85$120.00Buy???%???%LLYEli Lilly and Company7/11/2025$790.23$942.00Buy???%???%CDTXCidara Therapeutics7/9/2025$49.41$69.00???%???%APGEApogee Therapeutics7/2/2025$44.26$116.00Buy???%???%AMLXAmylyx Pharmaceuticals6/24/2025$5.02$17.00Buy???%???%CDTXCidara Therapeutics6/24/2025$44.95$68.00Buy???%???%LLYEli Lilly and Company6/20/2025$757.47$936.00Buy???%???%CDTXCidara Therapeutics5/16/2025$24.01$50.00Buy???%???%TENXTenax Therapeutics5/15/2025$5.89$15.00Buy???%???%MLYSMineralys Therapeutics5/14/2025$15.35$48.00Buy???%???%LLYEli Lilly and Company4/14/2025$743.92$928.00Buy???%???%ARQTArcutis Biotherapeutics4/3/2025$15.71Buy???%???%VERVVerve Therapeutics3/25/2025$5.50Buy???%???%PCVXVaxcyte3/12/2025$72.86$160.00Buy???%???%PCVXVaxcyte2/26/2025$82.18$160.00Buy???%???%MTSRMetsera2/25/2025$29.81$56.00Buy???%???%ARQTArcutis Biotherapeutics2/24/2025$12.81Buy???%???%MLYSMineralys Therapeutics2/24/2025$9.27Buy???%???%ARQTArcutis Biotherapeutics2/10/2025$11.25Buy???%???%APGEApogee Therapeutics2/10/2025$39.22Buy???%???%ADGIAdagio Therapeutics12/15/2021$7.26Neutral???%???%MRKMerck & Co., Inc.12/7/2021$73.42$98.00Neutral???%???%ZLABZai Lab8/14/2020$79.65$111.00Buy???%???%ZLABZai Lab7/8/2020$82.81$105.00Buy???%???%LLYEli Lilly and Company11/26/2016$69.12$92.00Outperform???%???%TSROTesaro10/10/2016$120.28$115.00Outperform???%???%BMYBristol Myers Squibb10/9/2016$55.43$69.00Outperform???%???%AZNAstraZeneca10/9/2016$32.29$35.00Hold???%???%LLYEli Lilly and Company10/9/2016$82.09$103.00Buy???%???%ITCIIntra-Cellular Therapies9/30/2016$15.42$29.00Outperform???%???%BMYBristol Myers Squibb9/7/2016$56.96$75.00Buy???%???%TSROTesaro8/25/2016$87.11$108.00Outperform???%???%LLYEli Lilly and Company8/13/2016$80.22$105.00Outperform???%???%ITCIIntra-Cellular Therapies8/11/2016$41.25$95.00Buy???%???%BMYBristol Myers Squibb7/29/2016$74.66$85.00Buy???%???%MRKMerck & Co., Inc.7/14/2016$59.55$58.00Hold???%???%TSROTesaro6/30/2016$77.40$95.00Outperform???%???%ITCIIntra-Cellular Therapies6/30/2016$38.82Buy???%???%LLYEli Lilly and Company6/26/2016$74.33Buy???%???%ITCIIntra-Cellular Therapies6/22/2016$35.91Buy???%???%EPZMEpizyme6/21/2016$10.96$39.00Outperform???%???%AZNAstraZeneca6/16/2016$27.37$34.00Hold???%???%XLRNAcceleron Pharma6/12/2016$35.44Buy???%???%IMDZImmune Design6/10/2016$10.57Buy???%???%TSROTesaro6/6/2016$45.99Buy???%???%AGIOAgios Pharmaceuticals5/19/2016$45.30$56.00Market Perform???%???%ADROAduro Biotech5/17/2016$8.91$14.00Outperform???%???%IMDZImmune Design5/12/2016$11.13Buy???%???%ADROAduro Biotech5/5/2016$11.86$48.00Buy???%???%AZNAstraZeneca5/2/2016$28.96$34.00Market Perform???%???%LLYEli Lilly and Company5/2/2016$75.53$96.00Outperform???%???%NVSNovartis5/2/2016$76.84Hold???%???%ITCIIntra-Cellular Therapies4/30/2016$34.32Buy???%???%BMYBristol Myers Squibb4/27/2016$70.86Buy???%???%EPZMEpizyme4/19/2016$12.71Buy???%???%AZNAstraZeneca4/17/2016$29.71Hold???%???%ITCIIntra-Cellular Therapies4/16/2016$35.34Outperform???%???%TSROTesaro4/11/2016$45.20Buy???%???%MRKMerck & Co., Inc.4/5/2016$54.40Market Perform???%???%LLYEli Lilly and Company4/5/2016$73.18Outperform???%???%ITCIIntra-Cellular Therapies3/21/2016$26.15$95.00Outperform???%???%EPZMEpizyme3/17/2016$9.86$39.00Outperform???%???%TSROTesaro3/14/2016$44.08$69.00Outperform???%???%BMYBristol Myers Squibb2/29/2016$62.25$80.00Outperform???%???%AGIOAgios Pharmaceuticals2/19/2016$37.15$56.00Market Perform???%???%SGENSeagen2/10/2016$29.04$52.00Outperform???%???%AZNAstraZeneca2/2/2016$32.53$38.00Market Perform???%???%LLYEli Lilly and Company1/29/2016$76.81$96.00Outperform???%???%MRKMerck & Co., Inc.1/22/2016$51.35$58.00Hold???%???%BMYBristol Myers Squibb1/22/2016$64.40Buy???%???%NVSNovartis1/19/2016$80.23$98.00Outperform???%???%LLYEli Lilly and Company12/29/2015$85.49Buy???%???%FGENFibroGen12/29/2015$30.08Buy???%???%LLYEli Lilly and Company12/28/2015$85.85$95.00Outperform???%???%FGENFibroGen12/23/2015$29.60Buy???%???%AZNAstraZeneca12/17/2015$33.36$37.00Hold???%???%ITCIIntra-Cellular Therapies12/11/2015$55.39Buy???%???%AGIOAgios Pharmaceuticals12/7/2015$61.89$62.00Market Perform???%???%LLYEli Lilly and Company11/12/2015$80.70$93.00Outperform???%???%BMYBristol Myers Squibb10/28/2015$66.80$77.00Buy???%???%MRKMerck & Co., Inc.10/26/2015$52.76$67.00Market Perform???%???%TSROTesaro10/16/2015$45.52Buy???%???%LLYEli Lilly and Company10/13/2015$79.44$90.00Outperform???%???%EPZMEpizyme9/28/2015$12.95$42.00Buy???%???%ITCIIntra-Cellular Therapies9/18/2015$55.60$95.00Outperform???%???%LLYEli Lilly and Company9/17/2015$89.98$93.00Buy???%???%ITCIIntra-Cellular Therapies9/16/2015$48.81$39.00Buy???%???%SGENSeagen8/19/2015$45.51Buy???%???%ITCIIntra-Cellular Therapies8/3/2015$29.10Buy???%???%BMYBristol Myers Squibb7/28/2015$64.66Buy???%???%NVSNovartis7/28/2015$102.79Buy???%???%LLYEli Lilly and Company7/28/2015$85.68Buy???%???%LLYEli Lilly and Company7/27/2015$84.15$93.00Outperform???%???%LLYEli Lilly and Company7/22/2015$85.57$92.00Buy???%???%LLYEli Lilly and Company6/11/2015$86.59$77.00Outperform???%???%MRKMerck & Co., Inc.5/12/2015$60.00$66.00Hold???%???%ITCIIntra-Cellular Therapies5/7/2015$21.86$39.00Outperform???%???%LLYEli Lilly and Company3/13/2015$69.56$77.00Outperform???%???%AGNAllergan2/5/2015$219.42Market Perform???%???%LLYEli Lilly and Company12/22/2014$72.40$76.00Buy???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.